The Medicines Evaluation Unit

The Medicines Evaluation Unit is a joint venture with a major university hospital and covenants all profits (through its charitable status) to support research and patient care in the National Health Service. The MEU specialises in performing clinical trials (from Phase I through to IV) in respiratory / inflammatory medicine and related areas. With the company's position within hospital premises it has the advantages of easier patient recruitment, specialist equipment and ITU access available, and is therefore ideally suited to perform early phase exploratory studies. The medical and scientific staff of the MEU have developed extensive experience from working within the Pharmaceutical Industry of the clinical development of many different compounds.